Read + Share
Amedeo Smart
Independent Medical Education
Rojas L, Muniz S, Medina L, Pena J, et al. Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer. PLoS One 2020;15:e0227961.PMID: 32023267
Email
LinkedIn
Facebook
Twitter
Privacy Policy